Literature DB >> 5638562

Melphalan therapy for plasma cell myeloma.

R Alexanian, D E Bergsagel, P J Migliore, W K Vaughn, C D Howe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5638562

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  22 in total

Review 1.  Novel Induction Regimens in Multiple Myeloma.

Authors:  Karie D Runcie; Tomer M Mark
Journal:  Curr Hematol Malig Rep       Date:  2015-12       Impact factor: 3.952

Review 2.  Immunocytoma o' mice an' men.

Authors:  J R Hobbs
Journal:  Br Med J       Date:  1971-04-10

3.  Myeloma nephropathy.

Authors:  Z Hanicki; P Hirszel; M Magdon; W Pajdak; W Szczepkowska; T Zebro
Journal:  Int Urol Nephrol       Date:  1972       Impact factor: 2.370

4.  Management of multiple myeloma.

Authors:  J S Malpas
Journal:  Br Med J       Date:  1969-04-19

Review 5.  Current therapeutic strategies for multiple myeloma.

Authors:  Yoshihiro Torimoto; Motohiro Shindo; Katsuya Ikuta; Yutaka Kohgo
Journal:  Int J Clin Oncol       Date:  2015-04-09       Impact factor: 3.402

Review 6.  Advances in treatment for relapses and refractory multiple myeloma.

Authors:  Tiffany Richards; Donna Weber
Journal:  Med Oncol       Date:  2010-03-06       Impact factor: 3.064

7.  Efficacy of the M-2 protocol in previously untreated patients with advanced multiple myeloma.

Authors:  H Gössinger; P Bettelheim; E Neumann; W Hinterberger; K Korninger; H Niessner; I Pabinger-Fasching; K Bauer; K Lechner
Journal:  Blut       Date:  1984-11

8.  Abnormal lipoproteins in multiple myelomatosis.

Authors:  A Avgerinos; P Skliros; J Pyrovolakis; D Stathakos
Journal:  J Clin Pathol       Date:  1977-09       Impact factor: 3.411

9.  Plasma cell myeloma: response of melphalan-resistant patients to high-dose intermittent cyclophosphamide.

Authors:  D E Bergsagel; D H Cowan; R Hasselback
Journal:  Can Med Assoc J       Date:  1972-11-04       Impact factor: 8.262

10.  Pharmacokinetics of high-dose melphalan in children and adults.

Authors:  A Gouyette; O Hartmann; J L Pico
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.